PMS2 is thought to be the MMR mutated gene that confers the lowest risk of developing CRC, which is estimated to be around 10% by the age of 70 [37], consistent with an overall lower penetrance of mutations occurring in this gene [36]. This evidence concerns the gene PMS2 and colorectal carcinoma.